Kemwell Biopharma

In this modern technological world, India is getting ahead of many countries in terms of contract manufacturing and various developments.   Due to the high quality of international standards of the medicines available at low costs, India has chosen it with positive mode. It is an innovative and creative technique which can help in matching the changing trends in the field of medicines. It is a really dynamic and transitional field where one has to face lot of challenges and you also need to find out the growth options for it. It can be really possible for India to setup CMOs permanently up to the ground level in the near future. Due to increasing diseases,    the manufacture of drugs is also increasing and that’s why it has become important for the manufacturers to focus on the production of high-quality medicines. There are tight norms for the manufacturing of clinical trials, patents along with research in the medicinal field. The MNCs are really knowledge-based b...

These days,    the diseases are increasing rapidly and there are numerous patients in the world who are waiting for the high quality of medicinal treatment. Due to the growth of the diseases, the dependency on drugs and biologics is increasing and that’s why it has become important that ensure that proper quality of the drug manufacturing procedure. Vaccinations’ and biological drugs are basically manufactured with high-quality proteins in the living organisms but one can say that this procedure isn’t totally reliable. Proteins productions can’t be always accurate and that’s why these can be also ineffective on the targets. There is another problem which is that if the cells aren’t able to produce the right amount of protein, then it would be beneficial for the patient. When there are diseases spreading all over the world, the Contract Manufacturing organizations might be forced to produce high quality of medicines for meeting demands of the affected patients and t...

Do you know the role of automation in cell line development? The enhanced speed provides better quality, efficiency, and speed to the drug market. For a biopharmaceutical production company, the automated cell line has become really important but with the manual procedures, it can take a lot of time and difficult working tasks. The process can speed up using automated development and then the technicians can focus on the other important tasks they need to do. The date and timing of the cell growth can be scheduled according to the cell types. This helps the researchers to know the time when cells can be available for research projects. The certain factors which can limit the productivity in the automated process are the time required for assays, sub-clone of cells, maintenance and automation of cell-based protocols. There are a lot of automated platforms which are useful for reducing costs during the production of biopharmaceutical production. In the automated system, the...

Since the past few years, the protein therapeutics are the growth drivers of most of the biopharmaceutical companies. Some of the monoclonal antibody products are able to become one of the best selling medicines in the world. It has become quite challenging to produce biotherapeutics due to its complex and large sized molecules . Due to its fragile nature, manufacturers are forced to change the way they used to handle drug products earlier. The market of biologics is increasing during the past decade and the sales have been increased up to 20%. The living sources are used to extract drugs in case of biopharmaceutical drugs. Cells, nucleic acids, viruses, vaccines are some of the products which are used for the manufacture of these drugs . It might not be much difficult to carry on the production of biologics but these are expensive. Due to complex chains , it carries a lot of cost during the manufacture of these drugs.    The structure of the prot...